Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 8981 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Global Medical Plastics Strategic Research Report 2024-2030 - Pioneering New Frontiers in Medical Device Evolution

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

Single Use Assemblies (Biopharma, CROS & CMOS) Markets: Filtration, Cell Culture, Storage, Sampling, Fill-finish - Global Forecast to 2028

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

Preparative and Process Chromatography Research Report 2023

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

Global Automated Compounding Device (Oncology) Market Forecast Report to 2028: Increased Connectivity and Interoperability Drives Market Forward

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

Viral Vectors and Plasmid DNA Global Market Report 2024 - A 1.66 Billion Market by 2028, Registering a Forecasted 14.8% CAGR

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

AbbVie Unveils New Data from Robust Gastroenterology Portfolio at the 19th Congress of European Crohn's and Colitis Organisation (ECCO)

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024
Related companies:  AbbVie AB

Enzymatica publishes information memorandum about rights issue of shares

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024
Related companies:  Enzymatica AB

Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024
Related companies:  SciBase Holding AB

Groundbreaking Live Clinical Cases Completed with the Single Pass KRONOS Biopsy Closure Device

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

Government of Canada invests in RNA Technologies & Therapeutics' growth by boosting its expansion

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

Public advisory - APO-Mometasone nasal spray: Two lots recalled due to possible risk of infection

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

Vidac Pharma presents high efficacy in multiple solid tumor models for its next-generation cancer drug candidate and synergy with standard-of-care treatment in liver cancer organoids

Read more ››
By: GlobeNewswire - 19 Feb 2024

BioPorto A/S to host investor meetings on 22 February 2024

Read more ››
By: GlobeNewswire - 19 Feb 2024
Related companies:  BioPorto Diagnostics A/S

CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa

Read more ››
By: GlobeNewswire - 19 Feb 2024
Related companies:  CMR Surgical Ltd.

Certa Therapeutics’ FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis

Read more ››
By: GlobeNewswire - 19 Feb 2024
Related companies:  Certa Therapeutics

GN Store Nord A/S - Notice to convene the Annual General Meeting 2024

Read more ››
By: GlobeNewswire - 19 Feb 2024

New collaboration between Boehringer Ingelheim and Sleip leverages AI-technology to help detect lameness in horses

Read more ››
By: GlobeNewswire - 19 Feb 2024

Transactions in connection with share buy-back program

Read more ››
By: GlobeNewswire - 19 Feb 2024
Related companies:  Genmab A/S

Before Operational Stress (BOS) Joins Forces with Viewpoint to Illuminate Global Mental Health Crises

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024

Cellenkos Approved to Proceed with CK0803 Neurotrophic T regulatory Cell therapy to Treat Second Cohort in ALS Trial

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2024
Related companies:  Cellenkos Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑